Patient voice on management of facial dermatological adverse events with targeted therapies: a qualitative study
Open Access
- 2 May 2019
- journal article
- research article
- Published by Springer Nature in Journal of Patient-Reported Outcomes
- Vol. 3 (1) , 27
Abstract
With the increased use of targeted therapies in oncology, dermatological adverse events (dAEs) have drawn attention. Because the face is crucial for human identity and social interactions, facial dAEs have significant impact on a patient’s quality of life. This study aimed to explore patients’ experience with regard to the management of targeted oncological therapy-induced facial dAEs. In this qualitative study, 20 patients at a university hospital in Japan with advanced/metastatic cancer and targeted therapy-induced facial dAEs were individually interviewed to collect data. Thematic analysis was used to analyze the data. Patients with cancer and targeted oncological therapy-induced facial dAEs who were referred to the Department of Dermatology had certain expectations from specialist services. Three key themes were identified: professional input and advice, empathetic commitment to individual management, and integrated care across specialties. The referred patients with cancer and facial dAEs needed more in-depth information and advice from dermatological services and were reassured by the empathetic commitment to individual management in integrated care across specialties. These findings suggest that attention to the patient’s perspective with a “sick person first” attitude and a collaborative effort across different specialties is important to minimize the effects of facial dAEs on the quality of life of patients with cancer.Keywords
Funding Information
- Japan Society for the Promotion of Science (15H05081)
This publication has 23 references indexed in Scilit:
- Psychologic factors in the development of facial dermatosesClinics in Dermatology, 2014
- Psychologic consequences of facial dermatosesClinics in Dermatology, 2014
- Impact of Dermatologic Adverse Events on Quality of Life in 283 Cancer Patients: A Questionnaire Study in a Dermatology Referral ClinicAmerican Journal of Clinical Dermatology, 2013
- The predictive role of skin rash with cetuximab and panitumumab in colorectal cancer patients: a systematic review and meta-analysis of published trialsTargeted Oncology, 2013
- Advances in the Management of Cutaneous Toxicities of Targeted TherapiesSeminars in Oncology, 2012
- A qualitative study of the ramifications of rash from epidermal growth factor receptor (EGFR) inhibitorsPsycho-Oncology, 2010
- Skin Toxicity Evaluation Protocol With Panitumumab (STEPP), a Phase II, Open-Label, Randomized Trial Evaluating the Impact of a Pre-Emptive Skin Treatment Regimen on Skin Toxicities and Quality of Life in Patients With Metastatic Colorectal CancerJournal of Clinical Oncology, 2010
- Comparison of anxiety and depression in patients with acne vulgaris and healthy individualsIndian Journal of Dermatology, 2010
- Dermatologic Infections in Cancer Patients Treated With Epidermal Growth Factor Receptor Inhibitor TherapyJNCI: Journal of the National Cancer Institute, 2009
- Using thematic analysis in psychologyQualitative Research in Psychology, 2006